It is likely that ZMYND11 will be delocalized in chondroblastoma bearing H3.3 K36M mutation, and its localization will be altered in other G34 mutant-expressing tumors where K36 methylation is locally reduced. Here, ZMYND11 is linked to chondroblastoma.